Table 3.
Association between individual perceptions and ART adherence level
| Model component | LR Chi-square | df | P-value | Pseudo R-square | Explanatory power of the model | Reliability analysis (alpha) |
|---|---|---|---|---|---|---|
| Perceived threat | 0.72 | 1 | 0.400 | 0.13 | 13.0% | 0.8798 |
| Perceived benefit | 0.00 | 1 | 0.965 | 0.00 | 0% | 0.8437 |
| Perceived barrier | 0.44 | 1 | 0.510 | 0.10 | 10% | 0.6176 |
| Cues to action | 2.28 | 1 | 0.134 | 0.42 | 42.0% | 0.5460 |
| Perceived self-efficacy | 0.19 | 1 | 0.666 | 0.30 | 30% | 0.6350 |
| Modifying factors | 92.65 | 3 | 0.012* | 0.357 | 35.7% | 0.6637 |
| Integrated value mapping (IVM) (combination of all models excluding modifying factors) | 3.46 | 5 | 0.119 | 0.64 | 64.0% | 0.6637 |
ART, antiretroviral therapy; df, degrees of freedom; LR, likelihood ratio. *P < 0.05.